Invest now
Albert David share price
Balanced risk
- ₹692.45(-0.07%)July 22, 2026 15:23:01 PM IST
- NSE
- BSE
- Vol : 1.90 K (NSE + BSE)Last 20 day avg : 2.34 K
Albert David is trading -0.07% lower at Rs 692.45 as compared to its last closing price. Albert David has been trading in the price range of 750.00 & 684.50. Albert David has given -5.47% in this year & -0.07% in the last 5 days. The company posted a net profit of -21.43 Crores in its last quarter.Listed peers of Albert David include Sun Pharmaceutical Industries (-0.98%), Divi's Laboratories (0.77%), Torrent Pharmaceuticals (0.06%).The Mutual Fund holding in Albert David was at 0.01% in 30 Jun 2026. The MF holding has decreased from the last quarter. The FII holding in Albert David was at 0.57% in 30 Jun 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 23 Jul 2026, 05:18 AM IST
- BetaMedium volatility1.11Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.08The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.72Annual dividends as a percentage of the stock price.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Albert David News
Albert David Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,942.95 | -0.98 | 4,66,167.81 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 7,386.75 | 0.77 | 1,96,095.00 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 5,042.00 | 0.06 | 1,70,697.42 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,417.10 | -1.08 | 1,14,479.76 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,129.75 | -1.22 | 1,13,038.19 | 21.19 | 4.24 | 0.09 | 14.22 |
Albert David Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-12 | Audited Results & Final Dividend |
| 2026-02-11 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-02 | Quarterly Results |
| 2025-05-13 | Audited Results & Final Dividend |
About the company Albert David
- IndustryBiotechnology & Drugs
- ISININE155C01010
- BSE Code524075
- NSE CodeALBERTDAVD
Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.
Albert David Share Price FAQs
Albert David is trading at 692.45 as on Wed Jul 22 2026 09:53:01. This is -0.07% lower as compared to its previous closing price of 692.95.
The market capitalization of Albert David is 395.94 Cr as on Wed Jul 22 2026 09:53:01.
The 52 wk high for Albert David is 938.75 whereas the 52 wk low is 581.30
Albert David can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 26.05
- Dividend Yield: 0.72%
- D/E ratio: 0.08
Albert David reported a net profit of -1.49 Cr in 2026.
The Mutual Fund Shareholding was 0.01% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Albert David QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.